Medicxi Ventures Management (Jersey) LTD Centessa Pharmaceuticals PLC Transaction History
Medicxi Ventures Management (Jersey) LTD
- $381 Million
- Q1 2024
A detailed history of Medicxi Ventures Management (Jersey) LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Medicxi Ventures Management (Jersey) LTD holds 19,963,157 shares of CNTA stock, worth $180 Million. This represents 59.15% of its overall portfolio holdings.
Number of Shares
19,963,157
Previous 19,963,157
-0.0%
Holding current value
$180 Million
Previous $159 Million
41.96%
% of portfolio
59.15%
Previous 60.15%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
73Shares Held
84.5MCall Options Held
17.7KPut Options Held
5K-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$90 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$87.4 Million2.56% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.62MShares$50.7 Million1.81% of portfolio
-
Vida Ventures Advisors, LLC3.93MShares$35.5 Million65.7% of portfolio
-
Perceptive Advisors LLC New York, NY3.08MShares$27.8 Million0.73% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $852M
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...